These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice. Bonfanti E, Bonifacino T, Raffaele S, Milanese M, Morgante E, Bonanno G, Abbracchio MP, Fumagalli M. Int J Mol Sci; 2020 Mar 31; 21(7):. PubMed ID: 32244295 [Abstract] [Full Text] [Related]
7. Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination. Coppolino GT, Marangon D, Negri C, Menichetti G, Fumagalli M, Gelosa P, Dimou L, Furlan R, Lecca D, Abbracchio MP. Glia; 2018 May 31; 66(5):1118-1130. PubMed ID: 29424466 [Abstract] [Full Text] [Related]
8. G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Differentiation in Response to Lysolecithin-Induced Demyelination. Lu C, Dong L, Zhou H, Li Q, Huang G, Bai SJ, Liao L. Sci Rep; 2018 Mar 14; 8(1):4502. PubMed ID: 29540737 [Abstract] [Full Text] [Related]
10. Adenosine A₂A receptors inhibit delayed rectifier potassium currents and cell differentiation in primary purified oligodendrocyte cultures. Coppi E, Cellai L, Maraula G, Pugliese AM, Pedata F. Neuropharmacology; 2013 Oct 14; 73():301-10. PubMed ID: 23770463 [Abstract] [Full Text] [Related]
11. Olig2-Targeted G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Survival in Response to Lysolecithin-Induced Demyelination. Ou Z, Sun Y, Lin L, You N, Liu X, Li H, Ma Y, Cao L, Han Y, Liu M, Deng Y, Yao L, Lu QR, Chen Y. J Neurosci; 2016 Oct 12; 36(41):10560-10573. PubMed ID: 27733608 [Abstract] [Full Text] [Related]
13. The role of the adenosinergic system in lung fibrosis. Della Latta V, Cabiati M, Rocchiccioli S, Del Ry S, Morales MA. Pharmacol Res; 2013 Oct 12; 76():182-9. PubMed ID: 23994158 [Abstract] [Full Text] [Related]
14. Purinergic signalling in brain ischemia. Pedata F, Dettori I, Coppi E, Melani A, Fusco I, Corradetti R, Pugliese AM. Neuropharmacology; 2016 May 12; 104():105-30. PubMed ID: 26581499 [Abstract] [Full Text] [Related]
16. [Recently identified GPR17 receptors--characteristics and role in pathology of the nervous system]. Wypych D. Postepy Biochem; 2014 May 12; 60(4):514-24. PubMed ID: 25807830 [Abstract] [Full Text] [Related]
17. Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine. Fumagalli M, Lecca D, Coppolino GT, Parravicini C, Abbracchio MP. Adv Exp Med Biol; 2017 May 12; 1051():169-192. PubMed ID: 28828731 [Abstract] [Full Text] [Related]
19. The G Protein-Coupled Receptor GPR17: Overview and Update. Marucci G, Dal Ben D, Lambertucci C, Santinelli C, Spinaci A, Thomas A, Volpini R, Buccioni M. ChemMedChem; 2016 Dec 06; 11(23):2567-2574. PubMed ID: 27863043 [Abstract] [Full Text] [Related]